This MSc is the only programme in the UK entirely focused on the imaging of cancer and has been purpose-built to meet a demand for expert researchers and clinicians. Medical imaging is central to the management of cancer, and this course has been designed to cover all aspects of imaging, from basic physics to image analysis. It also aims to give a solid grounding in current concepts of cancer biology and therapy as they apply ‘bench to bedside’.
Designed in close collaboration with a leading team of radiologists, medical physicists, oncologists and research specialists, the programme takes a theoretical and a practical approach to ensure it provides you with the specialist knowledge and skills required.
A key part of the programme is the study of real patient data and there are opportunities for project work in state-of-the-art clinical facilities for oncology imaging at both Hull Royal Infirmary and Castle Hill Hospital. You can also undertake preclinical research in the University's PET (Positron Emission Tomography) Research Centre, a recently completed cutting edge facility that hosts the only research-dedicated cyclotron in the UK, along with extensive radiochemistry provision and preclinical PET-CT and SPECT-CT scanners.
You study the basic theory and practice of image analysis and interpretation as well as advanced research applications. Students obtain a deep appreciation of the importance of image analysis as a discipline in the generation of scientific data that underpins patient management.
You gain an understanding of imaging theory, technology and application as relates to clinical practice across modalities, and of the biology of cancer as manifested in the clinic, integrated with key physiological and pharmacological concepts.
The programme aims to give graduate students from a range of backgrounds an understanding of imaging theory, an overview of the current understanding of cancer and how this underlies the use of imaging in patient management and the assessment of cancer treatments.
The programme comprises a combination of lectures, state-of-the-art computer-based image analysis, practical work, and projects supported by 'problem classes', workshops and tutorials.
A 12-week cancer imaging research project, carried out in the laboratory of an internationally-recognised cancer imaging scientist or clinician, is a key part of the course.
* All modules are subject to availability.
This MSc is designed for recent graduates who wish to pursue a career in medical imaging with a cancer focus.
The coverage of all aspects of medical imaging used in the management of cancer patients, from the basic physics through to clinical practice as seen in a modern UK NHS radiology department, also make it suitable for professionals working towards clinical qualification as well as those already qualified.
The programme is also the ideal pathway for biomedical science graduates or physicists who wish to develop their biological understanding of this disease prior to PhD study or employment in industry. Students will become independent life-long learners and scientific investigators with an ability to communicate across all disciplines involved with imaging.
Imaging has contributed to some of the most significant advances in biomedicine and healthcare and this trend is accelerating. This MSc, taught by leading scientists and clinicians, will equip imaging students from all science backgrounds with detailed knowledge of the advanced imaging techniques which provide new insights into cellular, molecular and functional processes, preparing them for a PhD or a career in industry.
Imaging is essential for diagnosis of disease and development of novel treatments. This programme focuses on translational medical imaging, and the development and use of preclinical imaging technologies to detect, monitor and prevent illnesses such as cancer, heart diseases and neurodegeneration. Students will undertake an independent research-based project in UCL’s world-class laboratories and develop their communication skills in biomedical science.
Students undertake modules to the value of 180 credits.
The programme consists of six core modules (120 credits), and a research dissertation (60 credits).
A Postgraduate Diploma (120 credits, full-time) is offered.
A Postgraduate Certificate (60 credits, full-time) is offered.
There are no optional modules for this programme.
All MSc students undertake an independent research project which culminates in a dissertation of 7,000 words or a manuscript suitable for submission to a peer-reviewed journal.
The programme is delivered through a combination of seminars, lectures, laboratory work, site visits and practicals. Assessment is through examination, presentations, essays, practical reports and the dissertation.
Further information on modules and degree structure is available on the department website: Advanced Biomedical Imaging MSc
UCL is involved in the dynamic and successful London-based entrepreneurial activity in biomedical imaging. It has a strong track record in placing postgraduates in key positions within industry (e.g. Siemens, Philips, GE Healthcare, GSK, SMEs and start-ups) and at other leading academic institutions with preclinical imaging facilities, including the Universities of Oxford and Cambridge in the UK, and MIT and NIH in the US. This MSc will provide ideal training for students who wish to apply to UCL’s EPSRC Centre for Doctoral Training in Medical Imaging.
This programme belongs to the School of Life and Medical Sciences; one of the largest and most prestigious aggregations of academics in its field, with a global reputation for teaching informed by cutting-edge research. Our close links with major hospitals and industry allow students to perform significant research projects. This laboratory experience makes them attractive applicants for PhD studentships or research assistant positions. Around 75% of our graduates have found research positions; either PhD studentships (50%) or research assistant positions (25%) in leading laboratories. Other graduates have taken up positions in industry or continued with specialist clinical training.
UCL offers a world-class environment in medical imaging and hosts several medical and biomedical imaging centres of excellence.
The UCL Centre for Advanced Biomedical Imaging is one of the world’s most advanced imaging centres, with 11 state-of-the-art imaging technologies, and is dedicated to developing imaging techniques of the future. Biomedical imaging is an interdisciplinary field drawing together biology, medicine, physics, engineering, and art.
The Research Excellence Framework, or REF, is the system for assessing the quality of research in UK higher education institutions. The 2014 REF was carried out by the UK's higher education funding bodies, and the results used to allocate research funding from 2015/16.
The following REF score was awarded to the department: Division of Medicine
80% rated 4* (‘world-leading’) or 3* (‘internationally excellent’)
Learn more about the scope of UCL's research, and browse case studies, on our Research Impact website.
Our MRes Oncology course will enable you to develop the skills and knowledge you need to prepare for a career in cancer research.
Cancer is a major cause of mortality and morbidity worldwide. Approximately 300,000 people develop the disease each year in the UK.
Understanding the basis of tumourigenesis and developing new therapies are high priority areas for investment, especially since the economic burden of cancer is increasing. The field of oncology encompasses a wide variety of biological and physical sciences.
You will learn from renowned basic, translational and clinical scientists at the Manchester Cancer Research Centre, the Cancer Research UK (CRUK) Manchester Institute and The Christie NHS Foundation Trust, with a focus on developing practical research skills.
Our course covers the clinical and research aspects of cancer care, and you will have access to an exceptionally wide range of research projects in basic cancer biology, translational areas and clinical cancer care and imaging.
This MRes has both taught and research components and is suitable for those with little or no previous research experience.
Our MRes course aims to provide postgraduate level training that will equip you with the specialist knowledge and research skills to pursue a research career in the fields of medical and clinical oncology.
You will gain an understanding of the scientific basis of cancer and its treatments, as well as the skills needed to evaluate the potential efficacy of new treatments.
This course also offers the potential to:
Clinical and research components
This is one of only a handful of MRes Oncology courses in the UK. Unlike many other oncology courses, ours has both clinical and research elements, making it suitable for both medical undergraduates and graduates, as well as biomedical science graduates.
Our MRes is structured around a 2:1 split between laboratory/clinical-based research projects and taught elements.
Laboratory and clinical research experience is gained through two research placements, one lasting approximately ten weeks (October to December) and the second lasting approximately 25 weeks (January to August).
You may choose to carry out one project for both placements, which most students do, or separate projects for each placement.
Most research placements are based at the Christie site, either within the hospital, the Manchester Cancer Research Centre or CRUK Manchester Institute premises. Projects are also available on the Central Manchester University Hospitals and University Hospital of South Manchester sites.
A list of available projects will be provided to offer holders in August.
Students are assessed through oral presentations, single best answer exams, written reports and a dissertation.
The course features the following components:
The Research Methods course unit covers topics relating to:
The Clinical Masterclass course unit provides a truly multidisciplinary foundation in the key issues in oncology. Delivery is by lectures and site tours and these classes will offer the student the chance to debate with internationally recognised experts in their field. Areas covered include:
Following attendance at these classes, you will be able to understand how cancer is diagnosed and the principles of cancer surgery, radiotherapy and chemotherapy.
The Lecture Series course unit comprises two intensive one-week courses, one in November and the other in February. The November course covers the biological basis of chemotherapy, pharmacology and cancer biology. The February course covers the biological basis of radiotherapy and translational aspects of cancer research, including biomarkers and new technologies.
The Tutorial course unit allows students to choose from a selection of clinical and academic oncology topics. The unit aims to improve ability to interpret and criticise literature as well as improve verbal communication skills in a small group setting.
Our MSc in Cancer Biology and Radiotherapy Physics is ideal if you wish to pursue a career in cancer research and/or cancer therapy involving ionising radiation.
With around 40% of all cancer cure cases involving radiotherapy and the UK soon to have a proton therapy service, the need for multidisciplinary scientists in this field has never been greater.
We aim to develop multidisciplinary scientists to create the necessary skill base that will drive radiotherapy forward in the UK.
This course will enable you to train as a multidisciplinary scientist in this area by covering a variety of subjects in content that is delivered by staff with a range of expertise, including physicists, biologists, engineers, clinicians and oncologists.
Our collaboration with The Christie will allow you to undertake unique research projects in its radiotherapy facilities that cannot be carried out anywhere else in the UK or most of Europe.
This course aims to help you develop:
You will be taught by academics from the University and clinical scientists at The Christie, meaning both fundamental science and its clinical application will be covered equally.
Units are delivered in one-week blocks with a mix of face-to-face content delivery and hands-on practical sessions.
There will be a number of assessed and non-assessed activities to develop your key skills and expand your knowledge base.
There is an also online pre-course element, which will be the beginning of your multidisciplinary scientific journey.
After the taught units, there is an supervised research project that will put into practice the key skills and knowledge acquired in the taught component.
The taught units will be assessed through multiple choice exams and practical assessments.
The research project will be assessed through the submission of a short report and oral presentation.
The taught component, which includes the five core and three optional units, will amount to 120 credits of the 180 credits required for an MSc qualification.
The remaining 60 credits will be obtained through a supervised research project.
Much of the course content is delivered through a collaboration with The Christie .
Our collaboration with The Christie means you will have access to an MRI image guided radiotherapy linear accelerator and a proton therapy centre incorporating a dedicated research room for your research project.
You will also be able to access a range of library and IT facilities throughout the University.
Practical support and advice for current students and applicants is available from the Disability Advisory and Support Service .
Individual taught units from this MSc can be offered to industry and healthcare professionals as part of a career and professional development programme. Please contact us for further information.
This course will help you gain the knowledge and skills to become a leading healthcare scientist in the public or private sector.
It may also be of interest if you are a healthcare worker in the field of radiotherapy who wishes to advance your career.
The master's qualification gained could act as a stepping stone to further academic qualifications or careers involving medical science research.
Designed in close collaboration with an international team of clinicians and research specialists, this focused MSc provides an understanding of the causes and treatment of cancer from 'bench-to-bedside'. You study both theory and practice to gain the specialist knowledge and skills required to pursue an academic career in cancer research or move into the more applied fields of cancer treatment, hospital pathology or industry.
The University has an international reputation for medical research and places a strong emphasis on cancer. This MSc is taught by a team of cancer research-focused staff from the School with internal and external expert guest lectures and seminars. We enjoy close collaborative links with NHS clinicians, clinical researchers and oncology staff who also deliver aspects of the programme.
Students are immersed in an excellent research environment and infrastructure, specifically the recently completed £6 million, state-of-the-art, cancer research facility housed in the Allam Building. The University has invested in preclinical optical and radiological imaging and radiotherapy research. Students engage in research in cutting edge facilities employing these and other technologies used for the early diagnosis and treatment of cancer, both on campus and within the Hull Royal Infirmary and Castle Hill Hospital.
This MSc is delivered by leading academic cancer scientists, research specialists, consultant clinical and medical oncologists, diagnosticians, radiologists, nurses and cancer surgeons, through a combination of lectures, expert seminars, state-of-the-art oncology-based practicals and projects supported by 'problem classes', workshops and tutorials.
Laboratory-based work is an important part of the programme, which includes an extended 12-week oncology research project carried out in the laboratory of an internationally-recognised cancer researcher. This MSc programme is designed to provide a highly supportive environment, in which teamwork, project management and communication skills are as important as technical proficiency.
Students are provided with in-depth specialist knowledge and insight into the fundamentals of Translational Oncology, alongside research-led teaching into the practical applications of cancer research. There is a strong emphasis on scientific method and associated skills.
* All modules are subject to availability.
Graduates of the MSc will be highly attractive candidates for competitive PhD programmes with a basis in oncology.
The programme provides a platform for developing transferable skills that are appropriate for employment within industry, basic science laboratories, clinical laboratories, and education and research.
You also learn transferable skills, highly valued by employers in many fields, including team work, critical analysis, IT skills, time management, presentation skills, problem solving, project management and discipline.
Translational Cancer Medicine enables you to gain detailed knowledge and understanding of research methods applied to rational drug design, clinical study design, molecular and cell biology, tumour immunology, genetics and cancer imaging. You'll gain practical experience through two six-month laboratory rotations.
The Translational Cancer Medicine MRes study pathway offers unique opportunities for you to join experienced research teams and work on particular projects from the outset. This course will allow you to develop an in-depth understanding of research methods, and of how theoretical academic studies and skills relate to research projects.
You will explore Fundamentals of Translational Cancer Medicine, providing you with advanced knowledge and skills to conceptualise, design, conduct and critically appraise specialist research. You will gain hands on research experience in two six month lab projects.
We use lectures, seminars and group meetings to deliver most of the modules on the course.
On average teaching consists of:
You will also be expected to undertake a significant amount of independent study.
Typically, 1 credit equates to ten hours of work.
Throughout the year, you will also attend literature reviews and journal clubs that the labs/departments organise, as well as any other internal or external seminars deemed relevant to your projects/assignments.
The primary method of assessment for this course is a combination of written essays, a thesis (research report), a presentation/Q&A session regarding the research report and a draft of a scientific paper.
The study time and assessment methods detailed above are typical and give you a good indication of what to expect. However, they are subject to change.
Occupational health clearance will be required for some of the projects.
Future PhD studies. Clinical and non-clinical academic careers in cancer medicine.
Our multidisciplinary Medical Imaging Sciences MRes offers you the opportunity to undertake research in an exciting and rapidly evolving field. Medical imaging is growing in importance both in patient management and clinical decision making, and also in drug development and evaluation. You will work with a multidisciplinary team of academics directing a wide range of cutting-edge research projects, with an emphasis on putting ideas and theory into practice, literally “from bench to bedside”.
Our Medical Imaging Sciences course aims to provide graduates of chemistry, physics, computing, mathematics, biology, pharmacy or medicine with advanced training in the imaging field.
We have designed this course mainly to prepare you for a PhD, but it also serves as training for employment in hospitals and industry. The key components are two research projects, which may be built around different aspects of a single research area in medical imaging. Medical imaging is a rapidly expanding field that needs input from team members with knowledge and skills in these different areas (chemistry, physics, computing, mathematics, biology, pharmacy, medicine) to achieve its promise in improving patient care.
Our course consists of required and optional taught modules in semesters one and two, and two medical imaging-related research projects in semester two. You will begin with a 30-credit introductory module, which will introduce you to the general area of medical imaging in all its forms and give you a firm grounding in the core elements of the course and preparation for the later research projects. Following this, you will be able to choose optional modules from a range of multidisciplinary modules from other masters’ programmes offered by the School of Biomedical Engineering and Imaging Sciences..
Throughout the course you will be provided with Research Skills training including a dedicated 15-credit module covering the topic in semester two.
We also offer a selection of Cardiovascular Imaging modules, including Cardiovascular Imaging 1: SCMR and Cardiovascular Imaging 4: Introduction to Cardiovascular Physiology. We welcome applications from those with a background in Cardiovascular Imaging, and also from physicians, surgeons, technicians, cardiac physiologists and radiographers.
We use lectures, seminars and group tutorials to deliver most of the modules on the programme. You will also be expected to undertake a significant amount of independent study.
In full-time mode, attendance at lectures, tutorials, laboratory practicals, completing coursework assignments and private study is expected to fill a standard 40 hour week during the semester. The research project requires full time work at least during the months of June, July and August.
Typically, one credit equates to 10 hours of work
The programme is assessed by a variety of mechanisms including: unseen written examinations; practical laboratory work and reports; case studies and oral presentations; workshops; audio-visual presentations; and laboratory- or library-based research projects.
The study time and assessment methods detailed above are typical and give you a good indication of what to expect. However, they may change if the course modules change.
Expected destinations are study for PhD, employment (research or service) in the NHS and commercial nuclear medicine services, the pharmaceutical or medical engineering industry.
Our research aims to enhance understanding of disease processes in animals and to translate that understanding into improved therapies for both animal and human disease.
Research focuses on:
Most of our research is carried out within The Roslin Institute, which is incorporated with the School and is the major centre of research.
Studentships are of 3 or 4 years duration and students will be expected to complete a novel piece of research which will advance our understanding of the field. To help them in this goal, students will be assigned a principal and assistant supervisor, both of whom will be active scientists at the Institute.
Student progress is monitored in accordance with School Postgraduate (PG) regulations by a PhD thesis committee (which includes an independent external assessor and chair). There is also dedicated secretarial support to assist these committees and the students with regard to University and Institute matters.
All student matters are overseen by the Schools PG studies committee. An active staff:student liaison committee and a social committee, which is headed by our postgraduate liaison officer, provide additional support.
Students are expected to attend a number of generic training courses offered by the Transkills Programme of the University and to participate in regular seminars and laboratory progress meetings. All students will also be expected to present their data at national and international meetings throughout their period of study.
The Veterinary Campus at Easter Bush includes the new “state-of- the-art” Roslin Institute Building, the Small Animal and Large Animal Hospitals, the Riddell-Swan Cancer Imaging Centre as well as the New Vet School. Our facilities include: rodent, bird and livestock animal units and associated lab areas; comprehensive bioinformatic and genomic capability; a range of bioimaging facilities; extensive molecular biology and cell biology labs; café and auditorium where we regularly host workshops and invited speakers.
The Royal (Dick) School of Veterinary Studies (R(D)SVS) Clinical Training Programmes provide an opportunity for qualified veterinary surgeons to undertake a period of advanced clinical training in a variety of disciplines under the guidance and supervision of Royal College of Veterinary Surgeons, European and American veterinary specialists.
Our Senior Clinical Training Programmes (residencies) are designed to train research-literate clinicians with specialist knowledge and expertise in their chosen field thereby giving them the opportunity to pursue career goals in teaching, research, clinical service and/or specialist practice. The majority of our programmes are approved by the relevant UK and European Colleges (see individual programmes).
The most recent UK RAE results confirm the College as the UK’s top research medical school and its top research veterinary medical school.
Our research aims to enhance understanding of disease processes in animals and to translate that understanding into improved therapies for both animal and human disease.
The Royal (Dick) School of Veterinary Studies offers state of the art clinical facilities for the treatment of large and small animals in the Small Animal and Large Animal Hospitals and the Riddell-Swan Cancer Imaging Centre, with diagnostic support from our on-site Veterinary Pathology Unit.
The School also has excellent large and small animal and exotics first opinion practices as well as a working dairy farm.
We invite postgraduate research proposals in a number of disease areas that impact significantly on patient care. We focus on exploring the mechanisms of disease, understanding the ways disease impacts patients’ lives, utilising new diagnostic and therapeutic techniques and developing new treatments.
As a student you will be registered with a University research institute, for many this is the Institute for Cellular Medicine (ICM). You will be supported in your studies through a structured programme of supervision and training via our Faculty of Medical Sciences Graduate School.
We undertake the following areas of research and offer MPhil, PhD and MD supervision in:
Newcastle hosts one of the most comprehensive organ transplant programmes in the world. This clinical expertise has developed in parallel with the applied immunobiology and transplantation research group. We are investigating aspects of the immunology of autoimmune diseases and cancer therapy, in addition to transplant rejection. We have themes to understand the interplay of the inflammatory and anti-inflammatory responses by a variety of pathways, and how these can be manipulated for therapeutic purposes. Further research theme focusses on primary immunodeficiency diseases.
There is strong emphasis on the integration of clinical investigation with basic science. Our research include:
We also research the effects of UVR on the skin including mitochondrial DNA damage as a UV biomarker.
This area emphasises on translational research, linking clinical- and laboratory-based science. Key research include:
Focus is on applied research and aims to underpin future clinical applications. Technology-oriented and demand-driven research is conducted which relates directly to health priority areas such as:
This research is sustained through extensive internal and external collaborations with leading UK and European academic and industrial groups, and has the ultimate goal of deploying next-generation diagnostic and therapeutic systems in the hospital and health-care environment.
There is a number of research programmes into the genetics, immunology and physiology of kidney disease and kidney transplantation. We maintain close links between basic scientists and clinicians with many translational programmes of work, from the laboratory to first-in-man and phase III clinical trials. Specific areas:
We have particular interests in:
Novel non-invasive methodologies using magnetic resonance are developed and applied to clinical research. Our research falls into two categories:
Our studies cover a broad range of topics (including diabetes, dementia, neuroscience, hepatology, cardiovascular, neuromuscular disease, metabolism, and respiratory research projects), but have a common theme of MR technical development and its application to clinical research.
We focus on connective tissue diseases in three, overlapping research programmes. These programmes aim to understand:
This research theme links with other local, national and international centres of excellence and has close integration of basic and clinical researchers and hosts the only immunotherapy centre in the UK.
Genetic approaches to the individualisation of drug therapy, including anticoagulants and anti-cancer drugs, and in the genetics of diverse non-Mendelian diseases, from diabetes to periodontal disease, are a focus. A wide range of knowledge and experience in both genetics and clinical sciences is utilised, with access to high-throughput genotyping platforms.
Our scientists and clinicians use in situ cellular technologies and large-scale gene expression profiling to study the normal and pathophysiological remodelling of vascular and uteroplacental tissues. Novel approaches to cellular interactions have been developed using a unique human tissue resource. Our research themes include:
We also have preclinical molecular biology projects in breast cancer research.
We conduct a broad range of research activities into acute and chronic lung diseases. As well as scientific studies into disease mechanisms, there is particular interest in translational medicine approaches to lung disease, studying human lung tissue and cells to explore potential for new treatments. Our current areas of research include:
Our research projects are concerned with the harmful effects of chemicals, including prescribed drugs, and finding ways to prevent and minimise these effects. We are attempting to measure the effects of fairly small amounts of chemicals, to provide ways of giving early warning of the start of harmful effects. We also study the adverse side-effects of medicines, including how conditions such as liver disease and heart disease can develop in people taking medicines for completely different medical conditions. Our current interests include: environmental chemicals and organophosphate pesticides, warfarin, psychiatric drugs and anti-cancer drugs.
Our new School of Pharmacy has scientists and clinicians working together on all aspects of pharmaceutical sciences and clinical pharmacy.